跳至主要内容
临床试验/CTRI/2022/11/047583
CTRI/2022/11/047583尚未招募2 期

Efficacy of Kushmandaka Ghrita and Bramhi Ghrita in Mild Neuro Cognitive Disorder - A Randomised Controlled Clinical Trial

Dr Tasni Das0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age above 50 years of either sex
  • 2. Participants Diagnosed Mild NCD as per DSM V Criteria
  • 3. Those who are MMSE score lies between 19-23.
  • 4. Montreal cognitive assessment scale (MOCA <22)

排除标准

  • 1.Other Neurocognitive Disorders due to Parkinsonâ??s disease, Huntingtonâ??s disease
  • 2.Neuropsychiatric disorders such as Schizophrenia, Bipolar mood disorder,
  • Other neurotic disorders
  • 3.Systemic illnesses like known cases of Thyroid disorders, Hyper lipidemia,
  • Uncontrolled Diabetes and Hypertension
  • 4.Patient with substance abuse like alcohol tobacco etc
  • 5.Patients with clinically relevant depression.
  • [Cornell scale for depression in Dementia (CSDD) >10

研究者

发起方
Dr Tasni Das

相似试验